These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 28814453)
1. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow. Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453 [TBL] [Abstract][Full Text] [Related]
2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow. Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863 [TBL] [Abstract][Full Text] [Related]
3. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow. Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283 [TBL] [Abstract][Full Text] [Related]
4. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245 [TBL] [Abstract][Full Text] [Related]
5. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway. Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796 [TBL] [Abstract][Full Text] [Related]
6. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920 [TBL] [Abstract][Full Text] [Related]
7. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer. Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799 [TBL] [Abstract][Full Text] [Related]
8. Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6. Decker AM; Decker JT; Jung Y; Cackowski FC; Daignault-Newton S; Morgan TM; Shea LD; Taichman RS Transl Oncol; 2020 Jul; 13(7):100781. PubMed ID: 32361123 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Jung Y; Shiozawa Y; Wang J; McGregor N; Dai J; Park SI; Berry JE; Havens AM; Joseph J; Kim JK; Patel L; Carmeliet P; Daignault S; Keller ET; McCauley LK; Pienta KJ; Taichman RS Neoplasia; 2012 May; 14(5):429-39. PubMed ID: 22745589 [TBL] [Abstract][Full Text] [Related]
10. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling. Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103 [TBL] [Abstract][Full Text] [Related]
11. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470 [TBL] [Abstract][Full Text] [Related]
12. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase. Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954 [TBL] [Abstract][Full Text] [Related]
13. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2. Shain SA Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781 [TBL] [Abstract][Full Text] [Related]
14. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation. Cackowski FC; Taichman RS Bone; 2019 Feb; 119():82-86. PubMed ID: 29496517 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of Gas6 in intestinal tumorigenesis. Akitake-Kawano R; Seno H; Nakatsuji M; Kimura Y; Nakanishi Y; Yoshioka T; Kanda K; Kawada M; Kawada K; Sakai Y; Chiba T Carcinogenesis; 2013 Jul; 34(7):1567-74. PubMed ID: 23430954 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer dormancy and recurrence. Cackowski FC; Heath EI Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433 [TBL] [Abstract][Full Text] [Related]
17. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer. Axelrod HD; Valkenburg KC; Amend SR; Hicks JL; Parsana P; Torga G; DeMarzo AM; Pienta KJ Mol Cancer Res; 2019 Feb; 17(2):356-369. PubMed ID: 30291220 [TBL] [Abstract][Full Text] [Related]
20. Bone secreted factors induce cellular quiescence in prostate cancer cells. Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]